GCVI Summit 2018
Skip Content

20 March 2017

eGenesis proceeds to $38m series A

Heritage Provider Network is among a consortium of investors that provided $38m in series A capital to genome editing technology developer eGenesis.

Author: Thierry Heles, Reporter

US-based genetics technology developer eGenesis has raised $38m in a series A round backed by healthcare services provider Heritage Provider Network.